Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J Adds New Dimension To Drug Discovery Efforts With 3DP Acquisition

Executive Summary

Johnson & Johnson's purchase of 3-Dimensional Pharmaceuticals has more of a research focus than its other recent drug acquisitions
Advertisement

Related Content

Pharma/Biotech Deals: Are Today’s Collaborations Tomorrow’s Acquisitions?
Pharma/Biotech Deals: Are Today’s Collaborations Tomorrow’s Acquisitions?
J&J Increases Alza Ante By $5 Bil. Over Abbott: Concerta Has J&J Upbeat
Centocor
Centocor
Centocor Remicade RA Launch Will Get J&J Support, Ultram Experience
Advertisement
UsernamePublicRestriction

Register

PS041133

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel